14th Edition Biologics Formulation, Development and Drug Delivery

The marcus evans 14th Edition Biologics Formulation, Development and Drug Delivery conference taking place in London, UK on 13-15 September, 2023 will explore techniques in stability formulation for high-concentration proteins from leading biotech companies. There will be case studies and discussions on tackling the key challenges in developing drugs and enhancing patient delivery on a larger scale. It will also address the topic of novel drug modalities and their ability to go to market. The event will further focus on improving the quality and control of drug manufacturing, and boost the responsiveness in producing long-acting drugs to match global needs.

Attending This Premier marcus evans Conference Will Enable You to:

• Formulation Development for Paediatric Population
• Increase Bioavailability with Spray Drying
• Identify challenges in protein delivery for patients
• The administration of hazardous drugs: using CSTDs in hospitals
• Applying Lyophilization with ADCs
• Demonstrate In-Vivo Protein Stability

Best Practices and Case Studies from:

• Heloïse Audat, Head of Lab R&D, Sanofi
• Sune Klint Andersen, Principal Scientist Spray Drying, Janssen Pharmaceuticals
• Joel Richard, Chief Development Officer, Enterome
• Jonas Fast, Principal Scientist Pharmaceutical Development, Hoffmann-La Roche AG
• Senta Voss, Director Parenterals, Merck KGAa Darmstadt
• Joachim Schuster, Associate Principal Scientist, Lonza

For more information please contact: Ms Ria Kiayia, Digital Media and PR Marketing Executive at riak@marcusevanscy.com or visit: https://bit.ly/3V6Vtx1